文献速递重症综合管理与镇静镇痛

低剂量可乐定输注改善高依赖病房术后患者睡眠:一项随机安慰剂对照单中心试验

Low-dose clonidine infusion to improve sleep in postoperative patients in the high-dependency unit. A randomised placebo-controlled single-centre trial.
PubMed 文献 · Intensive Care Med · 2024-09-23
一句话结论择期手术后入住高依赖病房的患者,术夜接受可乐定0.3 μg/kg/h输注较安慰剂总睡眠时间延长100.8分钟(95%CI 38.2-163.4,p=0.002),主观睡眠更好,4例因心动过缓低血压停药。

CLONES试验为双盲、安慰剂对照、平行组预试验,纳入单中心学术医院成人择期手术后高依赖病房患者,术夜给予可乐定0.3 μg/kg/h或生理盐水安慰剂。主要终点为消费级活动记录仪/光电容积描记设备测得的总睡眠时间。改良意向性分析共80例(可乐定39例、安慰剂41例),可乐定组平均总睡眠时间497.2分钟 vs 安慰剂组396.4分钟,平均延长100.8分钟(95%CI 38.2-163.4,p=0.002),且主观睡眠整体更好;两组安全性无差异,4例可乐定组患者因心动过缓、低血压停药且无需额外治疗。

要点

  • 择期手术后高依赖病房成人患者,术夜可乐定0.3 μg/kg/h输注组总睡眠时间平均497.2分钟 vs 安慰剂组396.4分钟,平均延长100.8分钟(95%CI 38.2-163.4,p=0.002)。
  • 可乐定组患者主观报告整体睡眠更好。
  • 4例可乐定组患者因心动过缓、低血压停药,均无需额外治疗;两组安全性结局无差异。
  • 研究期间仅1例患者在输注研究药物前出现谵妄,研究结束时无谵妄发生。
  • 该研究为单中心预试验,共随机83例,3例无数据,改良意向性分析纳入80例(可乐定39例、安慰剂41例)。

适用人群与场景

  • 单中心学术医院成人择期手术后入住高依赖病房(HDU)的患者。

处置流程与药物剂量

  • 术夜给予可乐定0.3 μg/kg/h或生理盐水安慰剂输注,非滴定给药。

红旗征与不能漏的情况

  • 4例可乐定组患者因心动过缓、低血压停药,均无需额外治疗。

研究设计与关键结果

  • CLONES为双盲、安慰剂对照、平行组预试验(pilot effectiveness randomised trial),单中心学术医院,随机83例,3例无数据,改良意向性分析80例(可乐定39例、安慰剂41例)。
  • 两组中位年龄相似(61岁和59岁),其他基线特征亦相似。
  • 主要终点:可乐定组平均总睡眠时间497.2分钟 vs 安慰剂组396.4分钟,平均延长100.8分钟(95%CI 38.2-163.4,p=0.002)。
  • 可乐定组患者报告整体睡眠更好。
  • 谵妄仅在1例患者于研究药物输注前观察到,研究结束时无谵妄发生。
  • 安全性结局两组无差异;4例可乐定组患者因心动过缓、低血压停药,无需额外治疗。

证据类型、等级与局限

  • 证据类型:双盲、安慰剂对照、平行组预试验(pilot effectiveness randomised trial)。
  • 局限:单中心;预试验;3例随机患者无数据,采用改良意向性分析处理缺失数据。

对床旁实践的改变

  • 在择期手术后高依赖病房成人患者中,术夜低剂量非滴定可乐定输注与总睡眠时间延长和主观睡眠质量改善相关,但4例因心动过缓、低血压停药。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Dexmedetomidine increases sleep and reduces delirium in postoperative patients, but it is expensive and requires a monitored environment. Clonidine, another α 2-agonist, is cheaper and is used safely for other purposes in wards. We assessed whether clonidine would improve sleep in postoperative high-dependency unit (HDU) patients.

METHODS: The Clonidine at Low dosage postoperatively to Nocturnally Enhance Sleep (CLONES) study was a double-blind, placebo-controlled, parallel-group pilot effectiveness randomised trial involving adult elective surgery HDU patients in a single academic hospital. Patients received clonidine 0.3 μg/kg/h or saline placebo on the night of surgery. The primary outcome was total sleep time measured using a consumer actigraphy/photoplethysmography device.

RESULTS: Of the 83 randomised patients, three had no data available, leaving 80 (39 clonidine, 41 placebo) in the intention-to-treat analysis, modified for missing data. Median patient ages of the groups were similar (61 and 59 years), as were other baseline characteristics. Clonidine patients had a mean of 100.8 (95% confidence interval [CI] 38.2-163.4) minutes (p = 0.002) longer total sleep time (mean 497.2 vs. 396.4 min) and reported better sleep overall. Delirium was only observed in one patient prior to study drug infusion, and none at the end of the study. Safety outcomes were not different. Four clonidine patients had their medication ceased due to bradycardia and hypotension that required no additional treatment.

CONCLUSION: Among postoperative elective surgical patients admitted to HDU, low-dose non-titrated clonidine, compared to placebo, was associated with longer and subjectively better-quality sleep.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Liu D, Hallt E, Platz A, et al. Low-dose clonidine infusion to improve sleep in postoperative patients in the high-dependency unit. A randomised placebo-controlled single-centre trial. Intensive Care Med. 2024. PMID: 39311905. doi:10.1007/s00134-024-07619-w

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。